azacitidine, 320-67-2

Articles:

PubMed:	Pharmacokinetics of different formulations of oral azacitidine (CC-486) and the effect of food and modified gastric pH on pharmacokinetics in subjects with hematologic malignancies.
PubMed:	Blastic plasmacytoid dendritic cell neoplasm: the first report of two cases treated by 5-azacytidine.
PubMed:	Efficacy and tolerability of treatment with azacitidine for 5 days in elderly patients with acute myeloid leukemia.
PubMed:	Azacitidine in the management of patients with myelodysplastic syndromes.
PubMed:	FDA drug approval summary: azacitidine (5-azacytidine, Vidaza) for injectable suspension.
PubMed:	Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias.
PubMed:	Induction of proto-oncogene BRF2 in breast cancer cells by the dietary soybean isoflavone daidzein.
PubMed:	Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management.
PubMed:	The demethylating agent 5-Aza reduces the growth, invasiveness, and clonogenicity of uveal and cutaneous melanoma.
PubMed:	Lower gastric secretion and higher incorporation of orotic acid into liver RNA in rats treated with 5-azacytidine and cycloheximide.
PubMed:	Subchronic oral toxicity study of decitabine in combination with tetrahydrouridine in CD-1 mice.
PubMed:	Vitamin A and beta-carotene inhibitory effect during 1,2-dimethylhydrazine induced hepatocarcinogenesis potentiated by 5-azacytidine.
PubMed:	Inhibition of aflatoxin metabolism and growth of Aspergillus flavus in liquid culture by a DNA methylation inhibitor.
PubMed:	Decitabine induces delayed reactive oxygen species (ROS) accumulation in leukemia cells and induces the expression of ROS generating enzymes.
PubMed:	Epigenetic action of decitabine (5-aza-2'-deoxycytidine) is more effective against acute myeloid leukemia than cytotoxic action of cytarabine (ARA-C).
PubMed:	Can hypomethylating agents provide a platform for curative therapy in myelodysplastic syndromes?
PubMed:	Chemical induction of endogenous retrovirus particles from the vero cell line of African green monkeys.
PubMed:	Approval summary: azacitidine for treatment of myelodysplastic syndrome subtypes.
PubMed:	Development of phenotypic screening assays for γ-globin induction using primary human bone marrow day 7 erythroid progenitor cells.
PubMed:	Activity of decitabine in patients with myelodysplastic syndrome previously treated with azacitidine.
PubMed:	Advances in myelodysplastic syndrome: nursing implications of azacitidine.
PubMed:	Boulevard of broken dreams: drug approval for older adults with acute myeloid leukemia.
PubMed:	Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management.
PubMed:	Reexpression of tumor suppressor, sFRP1, leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemoresistant cancers.
PubMed:	Azacitidine-associated hyperthermia and interstitial pneumonitis in a patient with myelodysplastic syndrome.
PubMed:	Reprogramming of pig dermal fibroblast into insulin secreting cells by a brief exposure to 5-aza-cytidine.
PubMed:	The NuRD complex cooperates with DNMTs to maintain silencing of key colorectal tumor suppressor genes.
PubMed:	Colon cancer cell apoptosis is induced by combined exposure to the n-3 fatty acid docosahexaenoic acid and butyrate through promoter methylation.
PubMed:	DNA demethylation and invasive cancer: implications for therapeutics.
PubMed:	Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer.
PubMed:	Folate deficiency induces dysfunctional long and short telomeres; both states are associated with hypomethylation and DNA damage in human WIL2-NS cells.
PubMed:	Economic analysis of decitabine versus best supportive care in the treatment of intermediate- and high-risk myelodysplastic syndromes from a US payer perspective.
PubMed:	Discovery of drugs that possess activity against feline leukemia virus.
PubMed:	Expression and immunotherapeutic targeting of the SSX family of cancer-testis antigens in prostate cancer.
PubMed:	MutS HOMOLOG1-derived epigenetic breeding potential in tomato.
PubMed:	Current status of epigenetic treatment in myelodysplastic syndromes.
PubMed:	Silencing of Wnt5a during colon cancer metastasis involves histone modifications.
PubMed:	Developmental toxicity and psychotoxicity of potassium iodide in rats: a case for the inclusion of behaviour in toxicological assessment.
PubMed:	Pharmacotherapy of myelodysplastic syndromes.
PubMed:	Current and novel therapeutic approaches in myelodysplastic syndromes.
PubMed:	DNA methyltransferases as targets for cancer therapy.
PubMed:	Myelodysplastic Syndromes: Diagnosis and Treatment.
PubMed:	Use of hypomethylating agents in myelodysplastic syndromes.
PubMed:	Allele-specific, age-dependent and BMI-associated DNA methylation of human MCHR1.
PubMed:	Epigenetics and oncology.
PubMed:	Epigenetic drugs against cancer: an evolving landscape.
PubMed:	MDS: Refining existing therapy through improved biologic insights.
PubMed:	DNA methylation and soy phytoestrogens: quantitative study in DU-145 and PC-3 human prostate cancer cell lines.
PubMed:	Character of the stimulatory response of uridine kinase in rat livers to cycloheximide treatment.
PubMed:	Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial.
PubMed:	Early detection of endogenous retroviruses in chemically induced mouse cells.
PubMed:	Epigenetic regulation of reelin and brain-derived neurotrophic factor genes in long-term potentiation in rat medial prefrontal cortex.
PubMed:	DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation.
PubMed:	Effects of specific DNMT gene depletion on cancer cell transformation and breast cancer cell invasion; toward selective DNMT inhibitors.
PubMed:	Optimal sequencing of treatments for patients with myelodysplastic syndromes.
PubMed:	Myc sensitizes p53-deficient cancer cells to the DNA-damaging effects of the DNA methyltransferase inhibitor decitabine.
PubMed:	Phase I clinical trial of oral rigosertib in patients with myelodysplastic syndromes.
PubMed:	DNA methyltransferase inhibitors in acute myeloid leukemia: discovery, design and first therapeutic experiences.
PubMed:	Lycopene and apo-10'-lycopenal do not alter DNA methylation of GSTP1 in LNCaP cells.
PubMed:	Decitabine.
PubMed:	Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia?
PubMed:	Risk-based management of myelodysplastic syndrome.
PubMed:	Decitabine and its role in the treatment of hematopoietic malignancies.
PubMed:	Developmental toxicity and psychotoxicity of sodium nitrite in rats.
PubMed:	Delivery of 5-aza-2'-deoxycytidine to cells using oligodeoxynucleotides.
PubMed:	New treatment for rare bone marrow condition.
PubMed:	Hematopoietic growth factors in myelodysplastic syndromes.
PubMed:	Regulatory approvals of pediatric oncology drugs: previous experience and new initiatives.
PubMed:	New approaches to the treatment of myelodysplasia.
PubMed:	DNA methylation and cancer therapy: new developments and expectations.
PubMed:	How much? How frequent? How long? A clinical guide to new therapies in myelodysplastic syndromes.
PubMed:	Epigenetics: the role of methylation in the mechanism of action of tumor suppressor genes.
PubMed:	Salmonella typhimurium strain TA100 differentiates several classes of carcinogens and mutagens by base substitution specificity.
PubMed:	Future directions in myelodysplastic syndrome: newer agents and the role of combination approaches.
PubMed:	Azacytidine (Vidaza(R)) in the treatment of myelodysplastic syndromes.
PubMed:	Treatment strategies to optimize clinical benefit in the patient with myelodysplastic syndromes.
PubMed:	Acute myeloid leukemia and myelodysplastic syndromes in older patients.
PubMed:	Targeted therapies in myelodysplastic syndrome.
PubMed:	Antiangiogenic therapy in myelodysplastic syndromes: is there a role?
PubMed:	Novel agents for the management of myelodysplastic syndromes.